Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tobias Grabe

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
ACS Medicinal Chemistry Letters|August 22, 2018
C797S Resistance: The Undruggable EGFR Mutation in Non-Small Cell Lung Cancer?Tobias Grabe, Jonas Lategahn, Daniel Rauh
Applied Optics|December 1, 2023
Parametric multiphysics study of focus-variable silicone lensesArved Ziebehl, Tobias Grabe, Tobias Biermann, et al.
ACS Medicinal Chemistry Letters|December 18, 2020
Complex Crystal Structures of EGFR with Third-Generation Kinase Inhibitors and Simultaneously Bound Allosteric LigandsJanina Niggenaber, Leonie Heyden, Tobias Grabe, et al.
ACS Medicinal Chemistry Letters|May 17, 2023
Addressing the Osimertinib Resistance Mutation EGFR-L858R/C797S with Reversible AminopyrimidinesTobias Grabe, Kirujan Jeyakumar, Janina Niggenaber, et al.
RSC Medicinal Chemistry|December 22, 2022
A high-throughput effector screen identifies a novel small molecule scaffold for inhibition of ten-eleven translocation dioxygenase 2Shubhendu Palei, Jörn Weisner, Melina Vogt, et al.
RSC Medicinal Chemistry|February 23, 2024
Correction: A high-throughput effector screen identifies a novel small molecule scaffold for inhibition of ten-eleven translocation dioxygenase 2Shubhendu Palei, Jörn Weisner, Melina Vogt, et al.
Journal of Medicinal Chemistry|September 15, 2020
Targeting Her2-insYVMA with Covalent Inhibitors-A Focused Compound Screening and Structure-Based Design ApproachJonas Lategahn, Julia Hardick, Tobias Grabe, et al.
Journal of Medicinal Chemistry|April 29, 2022
Insight into Targeting Exon20 Insertion Mutations of the Epidermal Growth Factor Receptor with Wild Type-Sparing InhibitorsJonas Lategahn, Hannah L Tumbrink, Carsten Schultz-Fademrecht, et al.
Chemical Science|December 21, 2019
Inhibition of osimertinib-resistant epidermal growth factor receptor EGFR-T790M/C797SJonas Lategahn, Marina Keul, Philip Klövekorn, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
ACS Medicinal Chemistry Letters|August 22, 2018
C797S Resistance: The Undruggable EGFR Mutation in Non-Small Cell Lung Cancer?Tobias Grabe, Jonas Lategahn, Daniel Rauh
Applied Optics|December 1, 2023
Parametric multiphysics study of focus-variable silicone lensesArved Ziebehl, Tobias Grabe, Tobias Biermann, et al.
ACS Medicinal Chemistry Letters|December 18, 2020
Complex Crystal Structures of EGFR with Third-Generation Kinase Inhibitors and Simultaneously Bound Allosteric LigandsJanina Niggenaber, Leonie Heyden, Tobias Grabe, et al.
ACS Medicinal Chemistry Letters|May 17, 2023
Addressing the Osimertinib Resistance Mutation EGFR-L858R/C797S with Reversible AminopyrimidinesTobias Grabe, Kirujan Jeyakumar, Janina Niggenaber, et al.
RSC Medicinal Chemistry|December 22, 2022
A high-throughput effector screen identifies a novel small molecule scaffold for inhibition of ten-eleven translocation dioxygenase 2Shubhendu Palei, Jörn Weisner, Melina Vogt, et al.
RSC Medicinal Chemistry|February 23, 2024
Correction: A high-throughput effector screen identifies a novel small molecule scaffold for inhibition of ten-eleven translocation dioxygenase 2Shubhendu Palei, Jörn Weisner, Melina Vogt, et al.
Journal of Medicinal Chemistry|September 15, 2020
Targeting Her2-insYVMA with Covalent Inhibitors-A Focused Compound Screening and Structure-Based Design ApproachJonas Lategahn, Julia Hardick, Tobias Grabe, et al.
Journal of Medicinal Chemistry|April 29, 2022
Insight into Targeting Exon20 Insertion Mutations of the Epidermal Growth Factor Receptor with Wild Type-Sparing InhibitorsJonas Lategahn, Hannah L Tumbrink, Carsten Schultz-Fademrecht, et al.
Chemical Science|December 21, 2019
Inhibition of osimertinib-resistant epidermal growth factor receptor EGFR-T790M/C797SJonas Lategahn, Marina Keul, Philip Klövekorn, et al.
Pageof 1